Cita APA

Alcón, C., Martín, F., Prada, E., Mora Graupera, J., Soriano, A., Guillén, G., . . . Montero, J. (2022). MEK and MCL-1 sequential inhibition synergize to enhance rhabdomyosarcoma treatment.

Citación estilo Chicago

Alcón, Clara, et al. MEK and MCL-1 Sequential Inhibition Synergize to Enhance Rhabdomyosarcoma Treatment. 2022.

Cita MLA

Alcón, Clara, et al. MEK and MCL-1 Sequential Inhibition Synergize to Enhance Rhabdomyosarcoma Treatment. 2022.